Association of Human Leukocyte Antigen Polymorphisms With Moderate-to-Severe Dry Eye With and Without Sjögren's Syndrome
Investigative Ophthalmology & Visual Science · 2025-07-22 · 66 (9) · 57
DOI: 10.1167/iovs.66.9.57 ↗At a glance
Journal article in Investigative Ophthalmology & Visual Science, published on 2025-07-22. Written by Zhiqing Chen and 10 co-authors. Institution: National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, China. Major MEDLINE topics: Sjogren's Syndrome, Dry Eye Syndromes, HLA Antigens, Polymorphism, Genetic. Cited 2 times so far (Crossref); 44 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Purpose
Sjögren's syndrome dry eye (SSDE) has been described in relation to human leukocyte antigen (HLA) polymorphisms. It is unknown whether non-Sjögren's syndrome dry eye (NSDE) is related to HLA. This study aimed to evaluate the genetic association of HLA polymorphism with dry eye disease (DED). This was a cross-sectional study.
Methods
Patients with moderate-to-severe DED with and without Sjögren's syndrome (SS) were included. Oral swab samples were collected and HLA genotyping was performed using single-molecule real-time sequencing. The normal healthy population was used as the control group for the susceptibility alleles identification. The signs and symptoms of DED were compared between patients with and without susceptibility alleles.
Results
Sixty-four (64) patients with NSDE (mean age = 47.55 years, 92.2% female) and 40 patients with SSDE (mean age = 52.68 years, 90% female) were included. HLA-B*40:01 allele frequency in the NSDE group was significantly higher than in the reference population (odds ratio [OR] = 2.42, P < 0.001). We identified a trend toward worsening of the ocular surface condition with HLA-B*40:01 carrier. This was manifested by a higher Oxford score (P < 0.0001) and more meibomian gland dropout (P = 0.030) and worse visual acuity (P = 0.006). Further analysis revealed that higher severe rate of NSDE was associated with HLA-B*40:01 carrier status (67.39% vs. 42.68%, P = 0.007). In addition, patients with SSDE showed a significantly higher frequency of HLA-B*40:01, HLA-C*07:02, HLA-DQB1*06:01, and HLA-DRB1*16:02. Patients with SSDE carrying HLA-B*40:01 had less tear secretion.
Conclusions
Significant associations exist between HLA alleles and moderate-to-severe DED. HLA polymorphisms were associated with the clinical features of moderate-to-severe DED, possibly via modulating the ocular surface immune function.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, China.
- Institute of PSI Genomics, Wenzhou Global Eye & Vision Innovation Center, Wenzhou, China.
- Cornea and External Eye Disease Service, Singapore National Eye Center, Singapore; Ocular Surface Research Group, Singapore Eye Research Institute, Singapore; Eye-Academic Clinical Program, Duke - National University of…
Cite
APA
Chen, Z., Jiang, D., Zheng, Q., Xing, S., Li, J., Lin, L., Ren, L., Xu, H., Yu, X., Tong, L., & Chen, W. (2025). Association of Human Leukocyte Antigen Polymorphisms With Moderate-to-Severe Dry Eye With and Without Sjögren's Syndrome. Investigative Ophthalmology & Visual Science, 66(9), 57. https://doi.org/10.1167/iovs.66.9.57
Vancouver
Chen Z, Jiang D, Zheng Q, Xing S, Li J, Lin L, et al. Association of Human Leukocyte Antigen Polymorphisms With Moderate-to-Severe Dry Eye With and Without Sjögren's Syndrome. Investigative Ophthalmology & Visual Science. 2025;66(9):57. doi:10.1167/iovs.66.9.57
BibTeX
@article{Chen2025,
author = {Chen, Zhiqing and Jiang, Dan and Zheng, Qinxiang and Xing, Shilai and Li, Jinyang and Lin, Lei and Ren, Li and Xu, Hanlu and Yu, Xiaoguang and Tong, Louis and Chen, Wei},
title = {Association of Human Leukocyte Antigen Polymorphisms With Moderate-to-Severe Dry Eye With and Without Sjögren's Syndrome},
journal = {Investigative Ophthalmology & Visual Science},
year = {2025},
volume = {66},
number = {9},
pages = {57},
doi = {10.1167/iovs.66.9.57}
}
EUVIMED